Evaluation of Meibomian Gland Dysfunction in Chinese Old Patients

NCT02481167 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-06-25

No results posted yet for this study

Summary

The purpose of this study is to identify age-related changes in chinese meibomian glands that may be associated with meibomian gland dysfunction (MGD).

Conditions

  • Dry Eye

Sponsors & Collaborators

  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • ZHAO YUNE, MS · Wenzhou Medical University

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-04-30
Completion
2018-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02481167 on ClinicalTrials.gov